Presentation TCT 2016 Device Overview and Ongoing Study Design: Kona WAVE IV Trial Presenter: Roland E Schmieder October 30, 2016 REGISTER for free or LOG IN to view this content Clinical Cardiology Presentation TCT 2016 Hypertension Up Next Presentation TCT 2016 Alcohol Chemical Neurolysis (Ablative Solutions): Peregrine Results and the Sham-controlled TARGET BP I Trial Presenter: David E. Kandzari October 30, 2016 More slides + Presentation TCT 2016 Assessment and Critical Appraisal of Ongoing RDN Studies: Will the Results Accurately Reflect RDN Effectiveness? Presenter: Justin E. Davies October 30, 2016 Presentation TCT 2016 Why are These Trials Recruiting Slowly and How Can We Improve Recruitment Rates? Presenter: Martin B. Leon October 30, 2016 We Recommend
Presentation TCT 2016 Alcohol Chemical Neurolysis (Ablative Solutions): Peregrine Results and the Sham-controlled TARGET BP I Trial Presenter: David E. Kandzari October 30, 2016
Presentation TCT 2016 Assessment and Critical Appraisal of Ongoing RDN Studies: Will the Results Accurately Reflect RDN Effectiveness? Presenter: Justin E. Davies October 30, 2016
Presentation TCT 2016 Why are These Trials Recruiting Slowly and How Can We Improve Recruitment Rates? Presenter: Martin B. Leon October 30, 2016